These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12101449)

  • 1. Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy.
    Hinton DR; He S; Jin ML; Barron E; Ryan SJ
    Eye (Lond); 2002 Jul; 16(4):422-8. PubMed ID: 12101449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.
    Cui JZ; Chiu A; Maberley D; Ma P; Samad A; Matsubara JA
    Eye (Lond); 2007 Feb; 21(2):200-8. PubMed ID: 16531976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte transglutaminase in proliferative vitreoretinopathy.
    Priglinger SG; Alge CS; Kreutzer TC; Neubauer AS; Haritoglou C; Kampik A; Welge-Luessen U
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4990-7. PubMed ID: 17065518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue growth factor as a mediator of intraocular fibrosis.
    He S; Chen Y; Khankan R; Barron E; Burton R; Zhu D; Ryan SJ; Oliver N; Hinton DR
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4078-88. PubMed ID: 18450591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model.
    Daftarian N; Baigy O; Suri F; Kanavi MR; Balagholi S; Afsar Aski S; Moghaddasi A; Nourinia R; Abtahi SH; Ahmadieh H
    Exp Eye Res; 2021 Jul; 208():108622. PubMed ID: 34022176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
    Lashkari K; Rahimi N; Kazlauskas A
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.
    Khankan R; Oliver N; He S; Ryan SJ; Hinton DR
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5068-78. PubMed ID: 21571675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-1 influences migration of retinal pigment epithelial cells.
    Alge CS; Priglinger SG; Kook D; Schmid H; Haritoglou C; Welge-Lussen U; Kampik A
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):415-26. PubMed ID: 16384992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment.
    Jin M; Chen Y; He S; Ryan SJ; Hinton DR
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):323-9. PubMed ID: 14691191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
    Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
    Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor promotes retinal pigment epithelium mesenchymal transition via the PI3K/AKT signaling pathway.
    Wang Y; Chang T; Wu T; Ye W; Wang Y; Dou G; Du H; Hui Y; Guo C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
    Briggs MC; Grierson I; Hiscott P; Hunt JA
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MeCP2-421-mediated RPE epithelial-mesenchymal transition and its relevance to the pathogenesis of proliferative vitreoretinopathy.
    Li X; Li X; He S; Zhao M
    J Cell Mol Med; 2020 Aug; 24(16):9420-9427. PubMed ID: 32638535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.
    Inoue T; Okada H; Kobayashi T; Watanabe Y; Kanno Y; Kopp JB; Nishida T; Takigawa M; Ueno M; Nakamura T; Suzuki H
    FASEB J; 2003 Feb; 17(2):268-70. PubMed ID: 12475893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy.
    Liang CM; Tai MC; Chang YH; Chen YH; Chen CL; Lu DW; Chen JT
    Acta Ophthalmol; 2011 Sep; 89(6):e505-14. PubMed ID: 21457483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of TGF-ß1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition.
    Hoerster R; Muether PS; Vierkotten S; Hermann MM; Kirchhof B; Fauser S
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):11-6. PubMed ID: 23680864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of connective tissue growth factor and its potential role in choroidal neovascularization.
    Watanabe D; Takagi H; Suzuma K; Oh H; Ohashi H; Honda Y
    Retina; 2005; 25(7):911-8. PubMed ID: 16205572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.